Timothy R Morgan MD

Gastroenterology•Long Beach, CA

Professor, Medicine, University of California, Irvine College of Medicine

Join to View Full Profile

5901 E 7th StVA Long Beach Healthcare System - 11Long Beach, CA 90822
Phone+1 562-826-5756
Fax+1 562-826-5436

Education & Training

LAC-USC Medical CenterFellowship, Hepatology, 1985 - 1986
University of Arizona College of Medicine-TucsonFellowship, Gastroenterology, 1983 - 1985
LAC-USC Medical CenterFellowship, Hepatology, 1982 - 1983
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1978 - 1982
Emory University School of MedicineClass of 1978

Certifications & Licensure

CA State Medical License 1979 - 2027
AZ State Medical License 1985 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Fellow (FAASLD) American Association for the Study of Liver Diseases, 2010
Fellow (FACP) American College of Physicians, 2005
Fellow (AGAF) American Gastroenterological Association, 2009

Clinical Trials

Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma Start of enrollment: 2008 Jul 01
Completed
Phase 2
Vitamin D + Telaprevir + Peginterferon + Ribavirin for of Hepatitis C Genotype 1 Start of enrollment: 2013 Aug 01
Withdrawn
Phase 2, Phase 3
A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis Start of enrollment: 2014 Dec 01
Completed
Phase 2
Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus Start of enrollment: 2014 Jul 01
Completed
Not Applicable
Pegfilgrastim in Patients With Alcoholic Hepatitis Start of enrollment: 2017 Jan 21
Completed
Phase 2
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine Start of enrollment: 2013 Nov 12
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

16 citations
Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.
Juan Pablo Arab, Luis Antonio Díaz, Jürgen Rehm, Gene Im, Marco Arrese
Journal of Hepatology. 2025-04-01
1 citations
Exome-wide association analysis identifies novel risk loci for alcohol-associated hepatitis.
Qiaoping Yuan, Colin Hodgkinson, Xiaochen Liu, Bruce Barton, Nancy Diazgranados
Hepatology. 2025-04-01
Secondary SBP Prophylaxis is associated with a higher rate of non-SBP infections in Two US-based National Cirrhosis Cohorts.
Scott Silvey, Nilang Patel, Jacqueline G O'Leary, Sofia S Jakab, Heather Patton
Clinical and Translational Gastroenterology. 2025-03-10

Journal Articles

The Veterans Affairs Hepatitis C Treatment Considerations
Timothy Morgan, MD, Nature

Press Mentions

American Liver Foundation and the United States Department of Veterans Affairs and Veteran Health Administration Partner to Help Veterans at Risk or Living with Liver DiseaseJanuary 23rd, 2025
Prolonged Alcohol Use and Its Detrimental Effects on Blood Protein SnapshotFebruary 10th, 2023
Pharmacists Could Play Bigger Role in Working with HCV PatientsFebruary 22nd, 2018

Grant Support

Genetic Risk Factors For Alcoholic Cirrhosis - Genome-Wide Case-Control StudyNational Institute On Alcohol Abuse And Alcoholism2011
Clinical Trial: HALT-CNational Center For Research Resources2008–2010
Core--BiostatisticsNational Institute On Aging1991–1996

Professional Memberships

American Gastroenterological Association - AGA
Fellow
American College of Physicians - ACP
Fellow
American Association for the Study of Liver Diseases
Fellow
European Association for the Study of the Liver
Member